Back to Search Start Over

60 - Brigatinib vs crizotinib in ALK TKI-naive ALK+ NSCLC: final results from ALTA-1L.

Authors :
Popat, Sanjay
Kim, Hye Ryun
Ahn, Myung-Ju
Yang, James
Han, Ji-Youn
Hochmair, Maximilian
Lee, Ki Hyeong
Delmonte, Angelo
Garcia Campelo, Maria
Kim, Dong-Wan
Griesinger, Frank
Felip, Enriqueta
Califano, Raffaele
Spira, Alexander
Gettinger, Scott
Tiseo, Marcello
Lin, Huamao
Liu, Yuyin
Vranceanu, Florin
Camidge, D
Source :
Lung Cancer (01695002). 2022 Supplement 1, Vol. 165, pS27-S28. 2p.
Publication Year :
2022

Subjects

Subjects :
*CRIZOTINIB
*NON-small-cell lung carcinoma

Details

Language :
English
ISSN :
01695002
Volume :
165
Database :
Academic Search Index
Journal :
Lung Cancer (01695002)
Publication Type :
Academic Journal
Accession number :
155190021
Full Text :
https://doi.org/10.1016/S0169-5002(22)00107-6
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details